Sandisk Hits Record High as AI Storage Demand Drives $245B Market Cap
Markets Daniel Marsh

Sandisk Hits Record High as AI Storage Demand Drives $245B Market Cap

Sandisk shares hit an all-time high of $1,562.34, pushing its market cap to $245 billion as AI data-center demand fuels a 251% revenue surge.

SNDK WDC MU
Hims & Hers Earnings: Weight-Loss Strategy in Focus as GLP-1 Shift Unfolds
Earnings James Calloway

Hims & Hers Earnings: Weight-Loss Strategy in Focus as GLP-1 Shift Unfolds

Hims & Hers Health reports Q1 earnings Monday after close, with Wall Street expecting ~$617M revenue. The key focus: how its weight-loss business performs after shifting from compounded GLP-1 drugs to FDA-approved options from Novo Nordisk.

HIMS LLY GDRX TNDM NVO
Everspin Technologies Surges on $40M Defense MRAM Deal
Technology Sarah Chen

Everspin Technologies Surges on $40M Defense MRAM Deal

Everspin Technologies shares rose 25% to $26.99 after announcing a $40 million defense subcontract for domestic MRAM production, with Q1 revenue reaching $14.9 million.

MRAM
Micron Surges on AI Memory Demand as Chip Rally Intensifies
Technology Sarah Chen

Micron Surges on AI Memory Demand as Chip Rally Intensifies

Micron Technology shares surged 15.5% to $746.81 on Friday, fueled by soaring demand for AI memory chips. Q2 revenue reached $23.86 billion, and Q3 guidance of $33.5 billion underscores the strategic importance of memory in AI.

MU SNDK SSNLF SOXX XLK
Australian Shares Tumble on US-Iran Tensions, CSL Plunges 18%
Markets Daniel Marsh

Australian Shares Tumble on US-Iran Tensions, CSL Plunges 18%

Australian shares opened lower as US-Iran tensions escalate and CSL's 18% plunge drags healthcare down 8%. Energy stocks provide the only bright spot.

CSL ASX SAN MET DYN
Pfizer's COVID Patent Woes Persist as Investors Eye Growth Beyond Vaccines
Regulation James Calloway

Pfizer's COVID Patent Woes Persist as Investors Eye Growth Beyond Vaccines

A Delaware federal judge dismissed Acuitas Therapeutics' attempt to clear Pfizer's Comirnaty vaccine from GSK patent claims, leaving the patent dispute unresolved. Pfizer shares fell 1.42% to $25.68.

PFE GSK LLY
Trade Desk Stock Slumps as Q2 Revenue Forecast Misses Wall Street Targets
Earnings James Calloway

Trade Desk Stock Slumps as Q2 Revenue Forecast Misses Wall Street Targets

The Trade Desk shares fell sharply after the company's Q2 revenue guidance of $750M missed analyst expectations of $771M, prompting multiple downgrades.

TTD
Fluence Energy Surges 27% on AI Data Center Deals, Record Backlog
Markets Daniel Marsh

Fluence Energy Surges 27% on AI Data Center Deals, Record Backlog

Fluence Energy stock soared 27.4% Friday after announcing master supply agreements with two major data-center clients and a record $5.6 billion backlog, despite a quarterly revenue miss.

FLNC
Palantir's AI Revenue Soars 85%, Yet Stock Stalls on Valuation Concerns
Earnings James Calloway

Palantir's AI Revenue Soars 85%, Yet Stock Stalls on Valuation Concerns

Palantir posted 85% Q1 revenue growth to $1.63B, lifted by U.S. defense deals, but the stock remains below pre-earnings levels as investors weigh high valuation.

PLTR
Archer Aviation Faces Pivotal Earnings After UAE Certification Milestone
Earnings James Calloway

Archer Aviation Faces Pivotal Earnings After UAE Certification Milestone

Archer Aviation's Midnight enters UAE Restricted Type Certificate program, a key step toward limited service in Abu Dhabi. Q1 results due Monday after market close.

ACHR JOBY
Plug Power Faces Pivotal Q1 Earnings After Margin Milestone
Earnings James Calloway

Plug Power Faces Pivotal Q1 Earnings After Margin Milestone

Plug Power reports Q1 earnings May 11 after its first positive gross margin in Q4. Investors focus on revenue growth, cash burn, and cost-cutting progress.

PLUG BLDP BE
ARK Buys CoreWeave Dip; Wells Fargo Lifts Target on $99B Backlog
Markets Daniel Marsh

ARK Buys CoreWeave Dip; Wells Fargo Lifts Target on $99B Backlog

ARK funds purchased 113,076 CoreWeave shares for $12.9M after the stock fell 11% on weak guidance. Wells Fargo raised its price target to $155, focusing on the company's $99.4B backlog.

CRWV ARKK ARKQ META NVDA